CCL2 and atherosclerosis: For example, in pathophysiological conditions such as atherosclerosis, hypomethylation of the promoter region of monocyte chemoattractant protein-1 (MCP-1) leads to increased expression of MCP-1 and promotes the recruitment of inflammatory cells accelerating the disease process (Liu et al., 2012).